Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is showing strong revenue growth in Q2, with solid progress in all its businesses. The company also has a large product potential in renewable fuel, making it an attractive stock. Despite its highly leveraged balance sheet, the company has potential for significant growth and is making good progress on key projects such as its biogas production facility. While there are risks to consider, the current valuation is attractive and potential upcoming catalysts may drive the stock further.

Bears say

Aemetis is facing significant challenges in terms of its historical financial losses and tight liquidity, which may hinder its growth and profitability in the future. While the company has shown progress in its key initiatives and has a strong financial plan, it has not recently updated its plan and is facing risks such as balance sheet/liquidity risks, political and regulatory risks, and changing macroeconomic factors. Additionally, its recent revenue growth for Q4 2025 was lower than expected and its estimates for 2026 have been lowered, indicating potential challenges in the near future for the company.

Aemetis (AMTX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.